Literature DB >> 28341345

The signaling signature of the neurotensin type 1 receptor with endogenous ligands.

Élie Besserer-Offroy1, Rebecca L Brouillette2, Sandrine Lavenus3, Ulrike Froehlich4, Andrea Brumwell5, Alexandre Murza6, Jean-Michel Longpré7, Éric Marsault8, Michel Grandbois9, Philippe Sarret10, Richard Leduc11.   

Abstract

The human neurotensin 1 receptor (hNTS1) is a G protein-coupled receptor involved in many physiological functions, including analgesia, hypothermia, and hypotension. To gain a better understanding of which signaling pathways or combination of pathways are linked to NTS1 activation and function, we investigated the ability of activated hNTS1, which was stably expressed by CHO-K1 cells, to directly engage G proteins, activate second messenger cascades and recruit β-arrestins. Using BRET-based biosensors, we found that neurotensin (NT), NT(8-13) and neuromedin N (NN) activated the Gαq-, Gαi1-, GαoA-, and Gα13-protein signaling pathways as well as the recruitment of β-arrestins 1 and 2. Using pharmacological inhibitors, we further demonstrated that all three ligands stimulated the production of inositol phosphate and modulation of cAMP accumulation along with ERK1/2 activation. Interestingly, despite the functional coupling to Gαi1 and GαoA, NT was found to produce higher levels of cAMP in the presence of pertussis toxin, supporting that hNTS1 activation leads to cAMP accumulation in a Gαs-dependent manner. Additionally, we demonstrated that the full activation of ERK1/2 required signaling through both a PTX-sensitive Gi/o-c-Src signaling pathway and PLCβ-DAG-PKC-Raf-1-dependent pathway downstream of Gq. Finally, the whole-cell integrated signatures monitored by the cell-based surface plasmon resonance and changes in the electrical impedance of a confluent cell monolayer led to identical phenotypic responses between the three ligands. The characterization of the hNTS1-mediated cellular signaling network will be helpful to accelerate the validation of potential NTS1 biased ligands with an improved therapeutic/adverse effect profile.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  G protein; G protein-coupled receptor (GPCR); Neuromedin N; Neuromedin N (PubChem CID: 9940301); Neurotensin; Neurotensin (1-13) (PubChem CID: 25077406); Neurotensin (8-13) (PubChem CID: 5311318); Neurotensin receptor 1; SR48692 (PubChem CID: 119192); β-arrestin

Mesh:

Substances:

Year:  2017        PMID: 28341345     DOI: 10.1016/j.ejphar.2017.03.046

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  15 in total

Review 1.  Neurotensin in reward processes.

Authors:  María Luisa Torruella-Suárez; Zoe A McElligott
Journal:  Neuropharmacology       Date:  2020-02-11       Impact factor: 5.250

2.  In Search of the Optimal Macrocyclization Site for Neurotensin.

Authors:  Marc Sousbie; Élie Besserer-Offroy; Rebecca L Brouillette; Jean-Michel Longpré; Richard Leduc; Philippe Sarret; Éric Marsault
Journal:  ACS Med Chem Lett       Date:  2018-01-29       Impact factor: 4.345

3.  Conformational Changes in Tyrosine 11 of Neurotensin Are Required to Activate the Neurotensin Receptor 1.

Authors:  Fabian Bumbak; Trayder Thomas; Billy J Noonan-Williams; Tasneem M Vaid; Fei Yan; Alice R Whitehead; Shoni Bruell; Martina Kocan; Xuan Tan; Margaret A Johnson; Ross A D Bathgate; David K Chalmers; Paul R Gooley; Daniel J Scott
Journal:  ACS Pharmacol Transl Sci       Date:  2020-04-29

4.  Neurotensin: A novel mediator of ovulation?

Authors:  Genevieve E Campbell; Hannah R Bender; Grace A Parker; Thomas E Curry; Diane M Duffy
Journal:  FASEB J       Date:  2021-04       Impact factor: 5.191

5.  Neurotensin differentially regulates bile acid metabolism and intestinal FXR-bile acid transporter axis in response to nutrient abundance.

Authors:  Jing Li; Jun Song; Baoxiang Yan; Heidi L Weiss; L Todd Weiss; Tianyan Gao; B Mark Evers
Journal:  FASEB J       Date:  2021-05       Impact factor: 5.834

6.  A split luciferase-based probe for quantitative proximal determination of Gαq signalling in live cells.

Authors:  Timo Littmann; Takeaki Ozawa; Carsten Hoffmann; Armin Buschauer; Günther Bernhardt
Journal:  Sci Rep       Date:  2018-11-21       Impact factor: 4.379

7.  Optimized Opioid-Neurotensin Multitarget Peptides: From Design to Structure-Activity Relationship Studies.

Authors:  Simon Gonzalez; Maria Dumitrascuta; Emilie Eiselt; Stevany Louis; Linda Kunze; Annalisa Blasiol; Mélanie Vivancos; Santo Previti; Elke Dewolf; Charlotte Martin; Dirk Tourwé; Florine Cavelier; Louis Gendron; Philippe Sarret; Mariana Spetea; Steven Ballet
Journal:  J Med Chem       Date:  2020-09-23       Impact factor: 7.446

8.  Structure of the neurotensin receptor 1 in complex with β-arrestin 1.

Authors:  Weijiao Huang; Matthieu Masureel; Qianhui Qu; John Janetzko; Asuka Inoue; Hideaki E Kato; Michael J Robertson; Khanh C Nguyen; Jeffrey S Glenn; Georgios Skiniotis; Brian K Kobilka
Journal:  Nature       Date:  2020-01-16       Impact factor: 69.504

9.  Analysis of β2AR-Gs and β2AR-Gi complex formation by NMR spectroscopy.

Authors:  Xiuyan Ma; Yunfei Hu; Hossein Batebi; Jie Heng; Jun Xu; Xiangyu Liu; Xiaogang Niu; Hongwei Li; Peter W Hildebrand; Changwen Jin; Brian K Kobilka
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-31       Impact factor: 11.205

10.  Ionic and signaling mechanisms involved in neurotensin-mediated excitation of central amygdala neurons.

Authors:  Saobo Lei; Binqi Hu
Journal:  Neuropharmacology       Date:  2021-07-14       Impact factor: 5.273

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.